t
Oxford Nanopore Technologies plc announced on 08 August 2025 that its Board intends to re-appoint Deloitte LLP as external auditor, effective from the financial year ending 31 December 2026. This decision followed a formal competitive tender process and coincides with the mandatory lead audit partner rotation. The re-appointment is subject to shareholder approval at the company's 2026 Annual General Meeting.
| Date | 8 Aug 2025 |
| Time | 07:00:10 |
| Category | Miscellaneous |
| ID | 5035U |
Oxford Nanopore Technologies plc
Result of Audit Tender
08 August 2025
Oxford Nanopore Technologies (LSE: ONT) ("Oxford Nanopore" or the "Group") the company behind a new generation of molecular sensing technology based on nanopores, today announces that, following the conclusion of a formal and competitive tender process for the role of Group statutory auditor, the Board intends to re-appoint Deloitte LLP ("Deloitte") as external auditor to take effect from, and including, the financial year ending 31 December 2026. This will coincide with the timing of the mandatory lead audit partner rotation.
The Group stated its intention to complete the tender for external audit services in its 2024 Annual Report and Accounts and a formal competitive tender process has been undertaken, in accordance with the Financial Reporting Council Minimum Standard, overseen by the Audit and Risk Committee.
Further details of the audit tender process and evaluation criteria will be included in the Group's 2025 Annual Report & Accounts. The appointment will be subject to shareholder approval at Oxford Nanopore's 2026 Annual General Meeting.
-ENDS-
For further information, please contact:
About Oxford Nanopore Technologies plc:
Oxford Nanopore Technologies' goal is to bring the widest benefits to society through enabling the analysis of anything, by anyone, anywhere. The Group has developed a new generation of nanopore-based sensing technology that is currently used for real-time, high-performance, accessible, and scalable analysis of DNA and RNA. The technology is used in more than 125 countries, to understand the biology of humans, plants, animals, bacteria, viruses and environments as well as to understand diseases such as cancer. Oxford Nanopore's technology also has the potential to provide broad, high impact, rapid insights in a number of areas including healthcare, food and agriculture.
For more information please visit: www.nanoporetech.com